DocSym
β
Searchsearch
Search
(C39.0) Malignant neoplasm: upper respiratory tract, part unspecified
More details coming soon
149 045 in individuals diagnosis malignant neoplasm: upper respiratory tract, part unspecified confirmed
21 657 deaths with diagnosis malignant neoplasm: upper respiratory tract, part unspecified
15% mortality rate associated with the disease malignant neoplasm: upper respiratory tract, part unspecified
Diagnosis malignant neoplasm: upper respiratory tract, part unspecified is diagnosed Men are 33.84% more likely than Women
99 741
Men receive the diagnosis malignant neoplasm: upper respiratory tract, part unspecified
13 124 (13.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
49 304
Women receive the diagnosis malignant neoplasm: upper respiratory tract, part unspecified
8 533 (17.3 %)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm: upper respiratory tract, part unspecified - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-5, 10-19, 25-94
Less common in men the disease occurs at Age 0-1, 5-9, 20-24, 95+Less common in women the disease occurs at Age 0-9, 20-24
In Women diagnosis is most often set at age 10-19, 25-95+
Disease Features malignant neoplasm: upper respiratory tract, part unspecified
Absence or low individual and public risk
Malignant neoplasm: upper respiratory tract, part unspecified - what does this mean
Malignant neoplasm of the upper respiratory tract, part unspecified, is an abnormal growth of cells that can form a tumor in the area of the upper respiratory tract such as the nose, throat, and larynx. it is caused by the uncontrolled growth of mutated cells that can spread to other areas of the body, leading to serious health complications.
What happens during the disease - malignant neoplasm: upper respiratory tract, part unspecified
Malignant neoplasm of the upper respiratory tract is caused by the uncontrolled growth of abnormal cells in the upper respiratory tract. these cells can spread to other parts of the body, leading to a wide range of symptoms depending on the type of tumor and its location. risk factors for developing malignancy in this area include smoking, exposure to environmental pollutants, and a weakened immune system. treatment options vary depending on the size and location of the tumor, but may include surgery, chemotherapy, and radiation.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Imaging tests (e.g. X-ray, CT scan, MRI)
- Endoscopy
- Biopsy
- Blood tests
- Urine tests
- Sputum tests
- Laryngoscopy
- Bronchoscopy
- Pulmonary function tests
Treatment and Medical Assistance
Main goal: Reduce the size of the malignant neoplasm and prevent it from spreading
- Surgery to remove the affected area
- Chemotherapy to target the malignant cells
- Radiation therapy to reduce the size of the neoplasm
- Immunotherapy to boost the body's natural defenses
- Targeted therapy to block the growth of cancer cells
- Hormone therapy to reduce the production of hormones that can fuel the growth of cancer cells
- Stem cell transplantation to replace damaged cells
19 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm: upper respiratory tract, part unspecified - Prevention
The best way to prevent malignant neoplasms in the upper respiratory tract is to avoid smoking, limit alcohol consumption, and maintain good oral health. additionally, regular screenings and check-ups are key in early detection and treatment of any potential malignancies.